HomeStocksTITANBIO

T

Titan Biotech

TITANBIO Share Price

Chemicals

468.55

14.10 (3.10%)profit

as on 02 Apr 2025 at 15:29

1D

BSE

Bulb

Today Titan Biotech opened at 460.00 while its previous close was at 454.45. In todays trading session TITANBIO reached a high of 472.80 and low of 453.00. The average traded price for today is 464.21. The 50 DMA stands at 42.75 and 200 DMA is at 54.17. Looking at intraday trend, the stock is in Uptrend.

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

TITANBIO Stock Performance

Markets Today

High

472.80

Low

453.00

Open at

460.00

Prev Close

454.45

Volumes

4,223

Avg Price

464.21

Lower Circuit

420.10

Upper Circuit

513.40

Last Traded Details

Quantity

9

Time

15:29:48

Price Movement

453.00
468.55
472.80
Loss 3.43%down side
up side0.90% profit

Historical Performance

3 M High

800.00

3 M Low

412.00

1 Yr High

1,017.85

1 Yr Low

412.00

3 Yr High

1,017.85

3 Yr Low

193.10

5 Yr High

1,017.85

5 Yr Low

44.20

1-Year Performance

412.00
468.55
1,017.85
loss3.43%down side
up side0.90% profit

TITANBIO Latest News

Steel Authority of India Limited (SAIL): US Tariffs May Redirect Global Steel Trade to India

sentiment_img

SAIL Chairperson Amarendu Prakash warns that US tariffs on European and Asian steel could redirect global steel trade to India, potentially increasing steel imports. The situation remains volatile, with potential reciprocal tariffs and tightening of EU quotas. India's government is aware and working on the situation.

6 hours ago

Trinity Realty: Rs 1,200 Crore Investment in Gurugram Luxury Housing Project

sentiment_img

Trinity is investing Rs 1,200 crore to develop 'Sky Palazzo Residences', a luxury housing project on Dwarka Expressway in Gurugram. The 11-acre project will be completed by 2029, with 345 apartments in the first phase.

7 hours ago

Coal India Ltd: Eyes Lithium Blocks in Australia and Argentina

sentiment_img

Coal India Ltd. is exploring lithium blocks in Australia and Argentina. The company aims to produce 875 million tonnes and have an offtake of 900 MT in FY 2025-26. A Rs 10 per tonne price hike for coking and non-coking coal was implemented from April 16. The company's pithead stock as of March 31, 2025, was 106 million tonnes, the highest to date.

7 hours ago

TITANBIO Share Price History

Close Price

Volume

TITANBIO share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
01 Apr 202539.7038.89
-2.19% Loss
39.7038.783,66,589
28 Mar 202540.5739.74
-1.86% Loss
40.5739.616,49,131
27 Mar 202540.3440.48
0.30% profit
40.6040.082,85,109
26 Mar 202540.6540.36
-0.72% Loss
40.9340.2612,59,667
25 Mar 202540.6640.65
1.28% profit
41.0440.3914,08,550
24 Mar 202539.8140.13
1.37% profit
40.4339.458,39,206
21 Mar 202539.0139.58
0.23% profit
39.8838.5315,08,398
20 Mar 202539.0339.49
1.29% profit
39.9639.0321,19,563
19 Mar 202539.5138.98
-1.21% Loss
39.5638.6820,87,374
18 Mar 202538.9439.45
1.37% profit
39.5538.866,24,381

TITANBIO Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

376

PE Ratio

16.70

PB Ratio

2.59

Dividend Yield

0.44%

ROE

17.73%

ROCE

23.79%

Book Value (₹)

175.44

Face Value (₹)

10.00


Share Holding Pattern

Held ByDec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters
55.88%55.88%55.88%55.88%55.88%
Domestic Institutional Investors (DII)
0.00%0.23%0.00%0.00%0.00%
Foreign Institutional Investors (FII)
0.00%0.00%0.00%0.00%0.00%
Public Investors
30.12%30.06%30.11%29.97%29.43%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


TITANBIO Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


TITANBIO Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA35.02Bullish
10-SMA35.98Bearish
20-SMA38.56Bearish
50-SMA42.75Bearish
100-SMA48.07Bearish
200-SMA54.17Bearish

Technical Indicators

IndicatorValueAction
RSI(14)39.03Neutral
ATR(14)2.82Less Volatile
STOCH(9,6)19.53Oversold
STOCH RSI(14)21.69Neutral
MACD(12,26)-0.19Bearish
ADX(14)21.43Weak Trend

Summary of Technical Indicators for TITANBIO


TITANBIO Financials Summary
View By:
Revenue

In Crores

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
4640444040
EBITDA

In Crores

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
118986

Net Profit

In Crores

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
75674
EPS
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
8.686.057.748.105.31

TITANBIO Financials

View By:

Income Statement

In Crores

Quarterly StatementDec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Revenue4640444040
Expenses3533353233
Operating Profit117885
Operating Profit Margin %23%18%19%19%13%
Other Income01102
Interest00000
Depreciation11111
Profit Before Tax106875
Tax %28%22%15%0%14%
Net Profit75674
EPS96885

Balance Sheet

In Crores

Yearly Balance SheetMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Share Capital88888
Reserve & Surplus316178102125
Minority Interest24000
Non Current Liabilities149544
Current Liabilities2019172019
Total Liabilities76101108135157
Fixed Assets3134353652
Capital Work in Progress004133
Investments0041528
Other Assets4567657074
Total Assets76101108135157

Cash Flow

In Crores

Yearly Cash FlowMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Operating Activities619222121
Investing Activities-2-5-16-21-20
Financing Activities-4-11-4-2-3
Net Cash Flow042-2-2
ScanX Logo

Get In-depth View of TITANBIO Quaterly Results, Balance Sheet, Cashflows & Corporate Action.

Use Screener

Corporate Actions

No Data

Sorry, No Corporate Actions at this Moment!


TITANBIO Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-24166
13.94% profit
24
12.55% profit
FY 2022-23146
16.55% profit
21
-3.04% Loss
FY 2021-22125
0.89% profit
22
-24.64% Loss






What’s New In The Market
news

At this moment, No news for this stock


FAQs

Titan Biotech share price as of today is ₹ 468.55 as on 02 Apr 2025 at 15:29.
The 52W high of Titan Biotech is ₹ 1,017.85 and 52W low is ₹ 412.00 as of 02 Apr 2025 at 15:29.
The past returns of Titan Biotech share are -
  • Past 1 year: -11.64%
  • Past 3 years: 73.09%
  • Past 5 years: 811.58%
The PE and PB ratio of Titan Biotech stands at 16.70 and 2.59 respectively as on 02 Apr 2025 at 15:29.
The EPS of Titan Biotech is 5.31 for the quarter ended Dec 2024 and 30.07 for the financial year 2023-24.
The shareholding pattern of Titan Biotech is as follows:
  • DIIs - 0.00%
  • FII - 0.00%
  • Promoters - 55.88%
  • Public Investors 29.43%
  • Goverenment - 0.00%
Yes, you can buy shares of Titan Biotech online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Titan Biotech stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Titan Biotech share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Titan Biotech.
You can easily buy the shares of Titan Biotech even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in TITANBIO
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India.
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client in the chat section are for support purposes only, and any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Saarthi 2.0 Mobile App for Investors